Drawing for NANOPDRN

USPTO serial 87470205

NANOPDRN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
REEVES, APRIL ELIZABETH
Law office
TMO LAW OFFICE 124 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NANOPDRN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001NUCLEIC ACID SEQUENCES, NAMELY, DNA USED IN THE MANUFACTURE OF COSMETICS; NUCLEIC ACID SEQUENCES, NAMELY, RNA USED IN THE MANUFACTURE OF COSMETICS; NUCLEIC ACID SEQUENCES USED IN THE MANUFACTURE OF COSMETICS; NUCLEIC ACID SEQUENCES, NAMELY, DNA FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; NUCLEIC ACID SEQUENCES, NAMELY, RNA FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; NUCLEIC ACID SEQUENCES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; NUCLEIC ACID SEQUENCES FOR SCIENTIFIC PURPOSES; NUCLEIC ACID SEQUENCES FOR SCIENTIFIC RESEARCH PURPOSESACTIVE
003COSMETICS; NON-MEDICATED MOUTH WASHES; COSMETIC PREPARATIONS FOR SKIN CARE; SKIN CLEANSERS; AFTER-SHAVE CREAMS; HAIR TONIC; MASK PACK FOR COSMETIC PURPOSES; COSMETIC PREPARATIONS AGAINST SUNBURN; COSMETIC PREPARATIONS FOR SKIN CARE AND SKIN TREATMENT; NON-MEDICATED SKIN CARE LOTIONS; COSMETIC CREAMS FOR SKIN CARE; NON-MEDICATED PREPARATIONS FOR THE ALLEVIATION OF SUNBURN; SKIN CLEANSING LOTIONS; COSMETIC PREPARATIONS FOR PROTECTING THE SKIN FROM THE SUN'S RAYS; HAIR CLEANING PREPARATIONSACTIVE
005PHARMACEUTICAL PREPARATIONS, NAMELY, ANTI-INFLAMMATORIES; PHARMACEUTICAL AGENTS FOR EPIDERMIS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS; PRE-PACKAGED INJECTABLE BIOCHEMICAL PHARMACEUTICAL PREPARATIONS FOR TISSUE REGENERATION; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF FACIAL WRINKLES; PHARMACEUTICAL PREPARATIONS FOR ACTIVATING CELLULAR FUNCTION; INJECTABLE PHARMACEUTICALS FOR TREATMENT OF OSTEOARTHRITIS; PHARMACEUTICAL PREPARATIONS FOR SKIN CARE; TISSUE ACTIVATING MEDICATED BRUSH-ON ORAL CARE GELS; PHARMACEUTICAL AGENTS AFFECTING PERIPHERAL NERVOUS SYSTEM; PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM; PHARMACEUTICAL AGENTS AFFECTING SENSORY ORGANS; BIOLOGICAL PREPARATIONS FOR THE TREATMENT OF INFLAMMATION AND TISSUE RESTORATION; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISORDERS; PHARMACEUTICAL AGENTS AFFECTING DIGESTIVE ORGANS; ANALGESICS; PHARMACEUTICAL AGENTS AFFECTING METABOLISM; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF MUSCLE PAIN; MUSCLE RELAXANTS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GASTRIC ULCER; EYE DROPS; OPHTHALMOLOGIC PREPARATIONS; PHARMACEUTICAL PREPARATIONS FOR EXTERNAL USE TO TREAT WOUNDS; SUPPOSITORIES; PAIN RELIEF PREPARATIONS; NUTRITIONAL TONICS IN THE NATURE OF POWDERED NUTRITIONAL SUPPLEMENT DRINK MIX; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION OF HAIR LOSS; PHARMACEUTICAL PREPARATIONS FOR THE REPAIR OF DAMAGE CAUSED BY RADIATION EXPOSURE; PHARMACEUTICAL PREPARATIONS FOR THE REPAIR OF DAMAGE CAUSED BY SUNLIGHT EXPOSURE; PHARMACEUTICAL PREPARATIONS FOR ACTIVATING FUNCTION OF NERVE CELL; PHARMACEUTICAL PREPARATIONS FOR ARTHRITIS; PHARMACEUTICAL PREPARATIONS FOR SKIN RENEWAL; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEURALGIA; HAIR GROWTH PREPARATIONS FOR MEDICAL PURPOSES; NUTRITIONAL SUPPLEMENTS; MEDICATED SKIN CARE LOTIONS; SKIN GRAFTS FOR MEDICAL PURPOSES; SYRINGES SOLD FILLED WITH PHARMACEUTICALS, NAMELY, ANTI-INFLAMMATORIES; BONE CEMENT FOR MEDICAL PURPOSESACTIVE
010MEDICAL APPARATUS AND INSTRUMENTS FOR USE IN DERMATOLOGY OR DERMATOPLASTY PROCEDURES; MEDICAL APPARATUS AND INSTRUMENTS FOR CARTILAGE RESTORATION; MEDICAL APPARATUS AND INSTRUMENTS FOR THE TREATMENT OF WRINKLES; MEDICAL APPARATUS AND INSTRUMENTS FOR ARTHRITIS TREATMENT; MEDICAL DEVICES FOR NONSURGICAL COSMETIC TREATMENTS; MEDICAL APPARATUS AND INSTRUMENTS FOR PLASTIC SURGERY; ARTIFICIAL BIOMATERIALS FOR AUGMENTATION OF TISSUE FOR MEDICAL PURPOSES; BONE PROSTHESESACTIVE
029SALMON NOT LIVE; PROCESSED FISH SPAWN; FISH FILLETSACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 27, 2018MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 27, 2018ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 1, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
May 1, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 1, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2017DOCKASSIGNED TO EXAMINER
Jun 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance